Strong Immunoexpression of Dickkopf-1 Is Associated with Response to Bortezomib in Multiple Myeloma

被引：2
|
作者：
Choi, Yong Won [1 ]
Kim, Tae Hwan [1 ]
Jeong, Seong Hyun [1 ]
Han, Jae Ho [2 ]
Park, Joon Seong [1 ]
机构：
[1] Ajou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea
[2] Ajou Univ Sch Med, Dept Pathol, Suwon, South Korea
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3270.3270
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3270
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma
    Choi, Yong Won
    Park, Joon Seong
    Han, Jae Ho
    Kim, Jang-Hee
    Ahn, Mi Sun
    Lee, Hyun Woo
    Kang, Seok Yun
    Choi, Jin-Hyuk
    Jeong, Seong Hyun
    LEUKEMIA & LYMPHOMA, 2018, 59 (11) : 2670 - 2678
  • [2] Dickkopf-1 and sclerostin in different phases of multiple myeloma; The effect of lenalidomide and dexamethasone treatment with or without bortezomib
    Terpos, E.
    Christoulas, D.
    Gkotzamanidou, M.
    Bratengeier, C.
    Gavriatopoulou, M.
    Woloszczuk, W.
    Kastritis, E.
    Dimopoulos, M. A.
    BONE, 2011, 48 : S254 - S254
  • [3] Bortezomib reduces serum dickkopf-1 and RANKL concentrations and normalizes indices of bone remodeling in patients with relapsed multiple myeloma.
    Terpos, Evangelos
    Heath, Deborah
    Rahemtulla, Amin
    Zervas, Kostas
    Chantry, Andrew
    Anagnostopoulos, Athanasios
    Pouli, Anastasia
    Katodritou, Eirini
    Verrou, Evgenia
    Vervessou, Elisavet C.
    Dimopoulos, Meletios A.
    Croucher, Peter
    BLOOD, 2006, 108 (11) : 153A - 153A
  • [4] Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma
    Qian, Jianfei
    Xie, Jin
    Hong, Sungyoul
    Yang, Jing
    Zhang, Liang
    Han, Xiaohong
    Wang, Michael
    Zhan, Fenghuang
    Shaughnessy, John D., Jr.
    Epstein, Joshua
    Kwak, Larry W.
    Yi, Qing
    BLOOD, 2007, 110 (05) : 1587 - 1594
  • [5] Epigenetic silencing of the WNT antagonist dickkopf-1(DKK1) in multiple myeloma
    Kocemba, K. A.
    Groen, R. W.
    Kersten, M. J.
    Bloem, A. C.
    Lokhorst, H. M.
    Spaargaren, M.
    Pals, S. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 117 - 117
  • [6] Dynamics of Bone Disease Biomarkers Dickkopf-1 and Sclerostin in Patients with Multiple Myeloma
    Gerov, Vladimir
    Gerova, Daniela
    Micheva, Ilina
    Nikolova, Miglena
    Mihaylova, Galya
    Galunska, Bistra
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [7] Dickkopf-1: a suitable target for the management of myeloma bone disease
    Gavriatopoulou, Maria
    Dimopoulos, Meletios-Athanasios
    Christoulas, Dimitrios
    Migkou, Magdalini
    Iakovaki, Marina
    Gkotzamanidou, Maria
    Terpos, Evangelos
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (07) : 839 - 848
  • [8] Inhibiting Dickkopf-1 (Dkk-1) prevents the development of osteolytic bone disease in multiple myeloma
    Heath, D. J.
    Chantry, A. D.
    Buckle, C.
    Coulton, L.
    Shaughnessy, J. D., Jr.
    Evans, H.
    Stover, D. R.
    Vanderkerken, K.
    Croucher, P. I.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 83 (01) : 6 - 6
  • [9] Platelet is a major contributor to circulating levels of Dickkopf-1: clinical implications in patients with multiple myeloma
    Voorzanger-Rousselot, Nathalie
    Goehrig, Delphine
    Facon, Thierry
    Clezardin, Philippe
    Garnero, Patrick
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (02) : 264 - 266
  • [10] Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma
    Qian, Jianfei
    Zheng, Yuhuan
    Zheng, Chengyun
    Wang, Lijuan
    Qin, Hong
    Hong, Sungyoul
    Li, Haiyan
    Lu, Yong
    He, Jin
    Yang, Jing
    Neelapu, Sattva
    Kwak, Larry W.
    Hou, Jian
    Yi, Qing
    BLOOD, 2012, 119 (01) : 161 - 169
12345